DCM Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-2,299
Closed -$364K 62
2024
Q1
$364K Sell
2,299
-3,786
-62% -$603K 0.15% 58
2023
Q4
$954K Buy
6,085
+3,024
+99% +$464K 0.34% 46
2023
Q3
$477K Sell
3,061
-120
-4% -$19.8K 0.22% 56
2023
Q2
$527K Hold
3,181
0.23% 55
2023
Q1
$493K Sell
3,181
-126
-4% -$20.3K 0.23% 51
2022
Q4
$584K Sell
3,307
-1,098
-25% -$190K 0.28% 51
2022
Q3
$720K Sell
4,405
-446
-9% -$75.5K 0.36% 70
2022
Q2
$861K Buy
4,851
+555
+13% +$98.9K 0.37% 69
2022
Q1
$762K Buy
4,296
+1,752
+69% +$298K 0.27% 94
2021
Q4
$435K Sell
2,544
-1,598
-39% -$262K 0.13% 147
2021
Q3
$669K Buy
+4,142
New +$707K 0.26% 109
2021
Q2
Sell
-8,204
Closed -$1.35M 255
2021
Q1
$1.35M Buy
+8,204
New +$1.33M 0.78% 29

Other funds holding JNJ

DCM Advisors's JNJ Position: Q2 2024 in Review

DCM Advisors sold out of Johnson & Johnson (JNJ) in Q2 2024, closing a stake of 2,299 shares — an estimated $364K sold.

DCM Advisors first reported a position in JNJ in Q1 2021 and held it in 12 quarters. The position peaked at $1.35M in Q1 2021. 3,802 funds tracked by Wall St. Rank hold JNJ as of Q2 2024.

  • DCM Advisors reported no remaining Johnson & Johnson position as of Q2 2024 after selling out during the quarter.
  • DCM Advisors sold 2,299 Johnson & Johnson shares in Q2 2024, an estimated $364K.
  • DCM Advisors first reported a position in Johnson & Johnson in Q1 2021 and held it in 12 quarters.
  • DCM Advisors's Johnson & Johnson position peaked at $1.35M in Q1 2021.
  • 3,802 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2024.

Based on DCM Advisors's 13F filing for Q2 2024, filed 15 Aug 2024.